| 1 |
29136201 | Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer. | 2018 Jan 1 |
1 |
| 2 |
28264648 | A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. | 2017 Mar 6 |
1 |
| 3 |
28424891 | A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors. | 2017 Oct |
1 |